BBA
BMRN icon

Baker Bros. Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,810,248
Closed -$337M 90
2023
Q3
$337M Hold
3,810,248
1.94% 5
2023
Q2
$330M Hold
3,810,248
1.91% 6
2023
Q1
$371M Sell
3,810,248
-3,810,246
-50% -$371M 2.02% 6
2022
Q4
$789M Hold
7,620,494
4.74% 4
2022
Q3
$646M Hold
7,620,494
4.23% 5
2022
Q2
$632M Hold
7,620,494
3.58% 4
2022
Q1
$588M Hold
7,620,494
3.38% 5
2021
Q4
$673M Hold
7,620,494
3.28% 6
2021
Q3
$589M Buy
7,620,494
+31,200
+0.4% +$2.41M 2.59% 7
2021
Q2
$633M Hold
7,589,294
2.78% 6
2021
Q1
$573M Hold
7,589,294
2.48% 8
2020
Q4
$666M Hold
7,589,294
2.51% 8
2020
Q3
$577M Hold
7,589,294
2.31% 7
2020
Q2
$936M Hold
7,589,294
4.13% 6
2020
Q1
$641M Hold
7,589,294
3.95% 6
2019
Q4
$642M Hold
7,589,294
3.41% 8
2019
Q3
$512M Hold
7,589,294
3.48% 8
2019
Q2
$650M Hold
7,589,294
4.42% 7
2019
Q1
$674M Hold
7,589,294
4.32% 8
2018
Q4
$646M Buy
7,589,294
+6,210
+0.1% +$529K 5.29% 6
2018
Q3
$735M Hold
7,583,084
4.84% 6
2018
Q2
$714M Hold
7,583,084
5.37% 5
2018
Q1
$615M Hold
7,583,084
5.21% 5
2017
Q4
$676M Buy
7,583,084
+1,677,411
+28% +$150M 5.86% 5
2017
Q3
$550M Hold
5,905,673
4.46% 5
2017
Q2
$536M Buy
5,905,673
+1,099,190
+23% +$99.8M 4.69% 5
2017
Q1
$422M Hold
4,806,483
3.45% 6
2016
Q4
$398M Hold
4,806,483
3.9% 8
2016
Q3
$445M Hold
4,806,483
4.04% 8
2016
Q2
$374M Hold
4,806,483
3.92% 8
2016
Q1
$396M Buy
4,806,483
+691,400
+17% +$57M 4.18% 8
2015
Q4
$431M Buy
4,115,083
+38,730
+1% +$4.06M 3.57% 10
2015
Q3
$429M Sell
4,076,353
-18,894
-0.5% -$1.99M 3.97% 9
2015
Q2
$560M Sell
4,095,247
-105,209
-3% -$14.4M 4.91% 7
2015
Q1
$523M Buy
4,200,456
+486,506
+13% +$60.6M 4.35% 7
2014
Q4
$336M Buy
3,713,950
+1,343,486
+57% +$121M 3.43% 12
2014
Q3
$171M Buy
2,370,464
+462,234
+24% +$33.4M 2.15% 12
2014
Q2
$119M Buy
1,908,230
+25,000
+1% +$1.56M 1.45% 14
2014
Q1
$128M Sell
1,883,230
-58,074
-3% -$3.96M 1.63% 13
2013
Q4
$137M Buy
1,941,304
+1,157,993
+148% +$81.5M 1.92% 12
2013
Q3
$56.5M Hold
783,311
0.8% 20
2013
Q2
$43.7M Buy
+783,311
New +$43.7M 0.86% 20